MSH2–MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes by Wilson, Teresa M. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
ARTICLE
 
637
 
JEM Vol. 201, No. 4, February 21, 2005 637–645 www.jem.org/cgi/doi/10.1084/jem.20042066
 
MSH2–MSH6 stimulates DNA polymerase 
 
 
 
, 
suggesting a role for A:T mutations 
in antibody genes
 
Teresa M. Wilson,
 
1 
 
Alexandra Vaisman,
 
2 
 
Stella A. Martomo,
 
3 
 
Patsa Sullivan,
 
1
 
Li Lan,
 
4 
 
Fumio Hanaoka,
 
5,6 
 
Akira Yasui,
 
4 
 
Roger Woodgate,
 
2
 
and Patricia J. Gearhart
 
3
 
1
 
Radiation Oncology Research Laboratory, Department of Radiation Oncology, University of Maryland, Baltimore, MD 21201
 
2
 
Section on DNA Replication, Repair and Mutagenesis, Laboratory of Genomic Integrity, National Institute of Child Health 
and Human Development, National Institutes of Health (NIH), Bethesda, MD 20892
 
3
 
Laboratory of Molecular Gerontology, National Institute on Aging, Bethesda, MD 20892
 
4
 
Department of Molecular Genetics, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan
 
5
 
Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
 
6
 
Discovery Research Institute, RIKEN and Core Research for Evolutional Sciences and Technology, Japan Science 
and Technology Corporation, Saitama 351-0198, Japan
 
Activation-induced cytidine deaminase deaminates cytosine to uracil (dU) in DNA, which leads 
to mutations at C:G basepairs in immunoglobulin genes during somatic hypermutation. The 
mechanism that generates mutations at A:T basepairs, however, remains unclear. It appears to 
require the MSH2–MSH6 mismatch repair heterodimer and DNA polymerase (pol) 
 
 
 
, as 
mutations of A:T are decreased in mice and humans lacking these proteins. Here, we 
demonstrate that these proteins interact physically and functionally. First, we show that 
MSH2–MSH6 binds to a U:G mismatch but not to other DNA intermediates produced during 
base excision repair of dUs, including an abasic site and a deoxyribose phosphate group. Second, 
MSH2 binds to pol 
 
  
 
in solution, and endogenous MSH2 associates with the pol in cell extracts. 
Third, MSH2–MSH6 stimulates the catalytic activity of pol 
 
  
 
in vitro. These observations 
suggest that the interaction between MSH2–MSH6 and DNA pol 
 
  
 
stimulates synthesis of 
mutations at bases located downstream of the initial dU lesion, including A:T pairs.
 
Somatic hypermutation generates substitutions
in Ig variable genes and switch regions before
heavy chain constant genes at an astounding
frequency of 10
 
 
 
2 
 
mutations per basepair. The
mutation pathway is initiated by the activation-
induced cytidine deaminase (AID) protein,
which is only expressed in B cells (1, 2). AID
deaminates cytosine on single-stranded DNA
substrates to generate uracil (dU) in vitro (3–9),
and these dUs could generate mutations of C:G
pairs in three ways. First, dU might be copied
by a high fidelity polymerase (pol) that inserts
A opposite U to produce C to T transitions
(10). Second, dU could be removed by dU
glycosylase (UNG) to produce an abasic site
(11–13), which is repaired during base exci-
sion repair by a low fidelity pol to produce
mutations at the site of the deaminated C (14).
Third, dU could be removed by UNG, and
the abasic site is copied by a translesion pol
to generate mutations opposite the site (15).
Thus, dU or an abasic lesion produces muta-
tion at C bases, or at G bases if C is deami-
nated on the complementary strand. Indeed,
mutations of C:G are predominantly observed
when AID is overexpressed in bacteria (10),
yeast (16), fibroblast cells (17), B cell lines (18,
19), and transgenic mice (20). However, the
spectrum of mutation in antibody genes from
mice and men includes mutations of A:T as
frequently as mutations of C:G, indicating that
other proteins (21), besides AID, participate in
the mutation pathway.
Among these proteins, the mismatch repair
MSH2–MSH6 heterodimer and DNA pol 
 
 
 
have been implicated in hypermutation. Ig
variable and switch regions from mice deficient
for Msh2 and Msh6 have the same frequency
of mutation as wild-type mice, but have fewer
mutations of A:T and correspondingly higher
mutations of C:G (22–29). MSH2–MSH6
must have a specialized function in hypermu-
tation that is separate from canonical mismatch
repair because mice deficient for other proteins
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in the repair pathway, Msh3, Pms2, and Mlh1, do not have a
strong bias for mutations of C:G in Ig genes (24, 26, 30–33).
Similarly, humans with the xeroderma pigmentosum
variant disease, who are deficient in the low fidelity DNA
pol 
 
 
 
, have a normal frequency of hypermutation in variable
and switch regions but fewer mutations of A:T (34–36). In
agreement with the genetic data, pol 
 
  
 
has been shown to
increase the frequency of substitutions of A:T basepairs on
DNA substrates in vitro in a manner that corresponds to
variable gene mutation (37, 38). However, mice deficient
for other low fidelity DNA pols, such as 
 
 
 
, 
 
 
 
, 
 
 
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
,
have no discernible change in the types of substitutions (39–
43), indicating that these pols either do not participate in hy-
permutation or their role is nonessential.
Because animals deficient for MSH2–MSH6 and pol 
 
 
 
exhibit the same phenotype of fewer mutations of A:T, we
considered the possibility that they may operate together in
the same branch of the hypermutation pathway. Our studies
revealed that MSH2–MSH6 not only binds to a U:G mis-
pair, but also physically interacts with pol 
 
  
 
and functionally
stimulates its catalytic activity.
 
RESULTS
MSH2–MSH6 binds to a U:G mismatch but not to an abasic 
site or a 5
 
 
 
-deoxyribose phosphate (dRP) group
 
MSH2–MSH6 might be recruited into the hypermutation
process by binding to an AID-induced U:G mispair or to a
DNA intermediate that would be produced during base exci-
sion repair. To test these possibilities, we generated DNA
substrates containing a U:G mismatch, an abasic site pro-
duced by the removal of U with UNG, and a dRP group
produced by nicking of the abasic site by an endonuclease.
For control substrates, homoduplex DNA was used as a nega-
tive control, and T:G heteroduplex DNA was used as a posi-
tive control. We assessed the ability of increasing amounts of
purified human MSH2–MSH6 to form complexes with each
of the DNA substrates by a gel mobility shift assay (Fig. 1).
MSH2–MSH6 bound to the U:G mismatch (K
 
d 
 
  
 
30.5 
 
 
 
0.6 nM) with about half of the affinity as for the control T:G
mismatch (K
 
d 
 
  
 
18.9 
 
  
 
0.6 nM). MSH2–MSH6 did not
bind to an abasic site or dRP lesion in this assay, nor did
MSH2–MSH3 bind to a U:G substrate (not depicted). Al-
though binding of MSH2–MSH6 to a U:G-containing sub-
strate has been reported previously (44), these data present a
systematic analysis of binding to various intermediates in the
base excision repair pathway. The results suggest that MSH2–
MSH6 can enter the hypermutation pathway by recognizing
an AID-induced U:G mispair or by binding to a T:G mispair
generated during error-prone base excision repair of dU (14).
 
MSH2 binds to pol 
 
 
 
Several techniques were used to detect an interaction be-
tween the mismatch repair proteins and pol 
 
 
 
. First, an
ELISA assay was used to see if the pol bound to intact MutS
complexes. As shown in Fig. 2, pol 
 
  
 
bound to both
MSH2–MSH3 and MSH2–MSH6 that were immobilized
on plastic microtiter plates, but not to BSA. The data were
analyzed by a Hill plot, and the apparent dissociation con-
stant (K
 
d
 
) for pol 
 
  
 
binding to MSH2–MSH3 was 7.4 
 
  
 
1.0
nM, and to MSH2–MSH6 was 6.5 
 
  
 
0.8 nM.
Second, pull-down experiments were performed with
the individual proteins to detect physical interactions in solu-
tion. The control for these reactions was pol 
 
 
 
, which has
been hypothesized to participate in hypermutation in a cell
line (45). COOH-terminal fragments comprising the last
233 amino acids of human pol 
 
  
 
and 224 amino acids of hu-
man pol 
 
  
 
were expressed as glutathione 
 
S
 
-transferase (GST)
fusion proteins in bacteria (Fig. 3 A). Individual subunits of
the human MutS proteins, MSH2, MSH3, and MSH6, were
translated in vitro with [
 
35
 
S]methionine and incubated with
beads coupled with either GST alone, GST–C-terminal pol
 
 
 
, or GST–C-terminal pol 
 
 
 
. As shown in Fig. 3 B, the
most efficient coprecipitation was between GST–pol 
 
  
 
and
MSH2, where 47% of the input MSH2 was pulled down in
the assay, but there was also significant binding of GST–pol
 
  
 
to MSH3 and MSH6. GST–pol 
 
  
 
also bound to MSH2
and MSH3, but at a much lower level, and there was no in-
teraction between the DNA pols and GST alone.
Third, coimmunoprecipitations with anti-FLAG anti-
body were performed using extracts from HeLa cells that
Figure 1. The MSH2–MSH6 heterodimer binds to a U:G mismatch. 
Increasing amounts of the MSH2–MSH6 complex (0–60 nM) were incu-
bated with 1 fmol of the various labeled 50-mer DNA substrates, which 
are depicted at the top of the figure. Bound complexes were detected by a 
shift in the substrate after electrophoresis. 
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were stably transfected with a vector that overexpressed
FLAG-tagged pol 
 
  
 
or with FLAG vector alone. As seen in
Fig. 3 C, Western blot analyses of the FLAG immunoprecip-
itates with anti-MSH2 antibodies showed that 
 
 
 
12% of the
input MSH2 could be precipitated from cell extracts express-
ing FLAG–pol 
 
 
 
. MSH2 did not precipitate with the FLAG
vector alone or with FLAG-XRCC1 (not depicted), which
is not involved in mismatch repair or translesion synthesis.
This demonstrates that endogenous MSH2 interacts with
overexpressed pol 
 
  
 
in vivo.
 
MSH2–MSH6 stimulates pol 
 
  
 
replication
 
In vitro primer extension assays were performed to determine
if MSH2–MSH6 altered the ability of pol 
 
  
 
to synthesize
DNA. Preliminary experiments revealed that DNA synthesis
by pol 
 
  
 
was similar on both recessed primer and one base–
gapped templates (not depicted). Recessed primer substrates
were used for all subsequent experiments because they would
resemble Ig substrates if long gaps were introduced by exonu-
clease activity near the AID lesion. Fig. 4 A shows the effect
of mismatch repair proteins on pol 
 
  
 
synthesis, using a DNA
template with dA as the first available base. Although the ad-
dition of MSH2–MSH3 had no obvious effect on primer
elongation by pol 
 
 
 
, the addition of MSH2–MSH6 appeared
to stimulate the activity of pol 
 
 
 
. In contrast, MSH2–MSH6
did not alter the ability of pol 
 
  
 
to elongate primers (Fig. 4 B).
The extent of stimulation of pol 
 
  
 
varied over a range of en-
zyme concentrations, and primer elongation was quantified
by a PhosphorImager and calculated as percent of total primer
termini. Stimulation was greatest at 14 nM enzyme, where
primer extension increased 10-fold, and was about twofold
greater on substrates with A or T as the first template base to
be copied, compared with when it was G or C (Fig. 4, A and
Figure 2. Pol   binds to MSH2–
MSH3 and MSH2–MSH6 heteroduplexes by ELISA analysis. Wells were 
coated with MSH2–MSH3 (diamonds), MSH2–MSH6 (squares), or BSA (trian-
gles) and incubated with increasing amounts of pol  . Bound protein was de-
tected with anti–pol   antibody. 
Figure 3. Pol   interacts with MSH2 in vitro and in vivo. (A) Coo-
massie-stained gel. An SDS-PAGE gel shows the purity of the GST-tagged 
COOH-terminal pols before they were coupled to glutathione-Sepharose 
beads. (B) GST pull-down assay. 35S-labeled MSH2, MSH3, and MSH6 pro-
teins were incubated with the pol-coupled beads and resolved on an SDS-
PAGE gel. Input lanes represent 100% of the MSH protein added to the 
assay tube. (C) Immunoprecipitation. FLAG-tagged pol   was overexpressed 
in HeLa cells and immunoprecipitated (IP) with or without antibody to 
FLAG protein. Precipitates were solubilized and separated by electrophoresis. 
The gel was immunoblotted (IB) for Western analyses using an antibody to 
FLAG to detect pol   and an antibody to MSH2. Input lanes represent 30% 
of the cell extracts used in the assay. 
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C). The MSH2–MSH6 complex also enhanced the ability of
pol 
 
  
 
to extend T:G and U:G mispaired primer termini, al-
though the amount of extended products at different pol 
 
 
 
concentrations was 
 
 
 
3–20-fold less than with the correctly
paired C:G termini (Fig. 5). It should be noted that the
length of the 18-mer primer and 40-mer template might be
too short for MSH2–MSH6 to bind to the mispaired termini,
and the observed stimulation might be through protein–pro-
tein interactions of the pol and repair complex.
Pol 
 
  
 
is a distributive enzyme and incorporates only a few
nucleotides before dissociating from the extended product
(46, 47). To determine the mechanism of how MSH2–
MSH6 stimulates the activity of pol 
 
 
 
, we tested the effect of
the complex on processivity and fidelity of the pol. Processiv-
ity, or the extent to which the pol elongates a primer in a sin-
gle encounter with the substrate, was measured in the pres-
ence of a DNA trap. Under these conditions, pol molecules
that dissociate from the radiolabeled DNA primer/template
Figure 4. Effect of mismatch repair proteins on DNA replication by 
pols   and  . All reactions were performed for 10 min. (A) Dose–response 
experiments depicting pol  –catalyzed primer extension in the presence 
of MSH2–MSH3 or MSH2–MSH6 with AT as the first two template bases 
to be copied. (B) Dose–response experiments depicting pol  –catalyzed 
primer extension in the presence of MSH2–MSH6 using the same template 
as in A. (C) Influence of template sequence context on the MSH2–MSH6-
dependent stimulation of primer extension by pol  . TA, GT, and CT repre-
sent the first two bases to be copied.
Figure 5. MSH2–MSH6 dependent stimulation of primer extension 
by pol   using matched (C:G) and mismatched (T:G or U:G) termini. 
All reactions were performed for 10 min. The graphs indicate quantitation 
of the gels and plot primer elongation catalyzed by pol   alone (closed 
circles) or in the presence of MSH2–MSH6 (open circles) as a percentage 
of total primer termini. 
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are trapped by binding to excess nonlabeled DNA. As shown
in Fig. 6 A, the processivity of pol 
 
  
 
did not change upon the
addition of MSH2–MSH6, and only one nucleotide was pre-
dominantly incorporated by the pol before dissociating from
the DNA template. Fidelity was assessed by primer extension
assays in the presence of individual nucleoside triphosphates.
As shown in Fig. 6 B, MSH2–MSH6 did not change the
overall fidelity of pol 
 
  
 
because the amount of A and G mis-
incorporation opposite template A was similar in the presence
and absence of the MSH complex.
To understand how MSH2–MSH6 stimulates the cata-
lytic activity of pol 
 
  
 
without changing its processivity or fi-
delity, we performed steady-state kinetic analyses of incor-
poration opposite template dA using standing start reaction
conditions where nucleotide insertion is measured at the first
template site adjacent to the original primer 3
 
  
 
terminus (48).
Although the absolute values of kinetic parameters V
 
max 
 
and
K
 
m 
 
derived from the standing start assay have limited mecha-
nistic significance, the ratios of V
 
max
 
/K
 
m 
 
should be a reliable
measure of the effect of MSH2–MSH6 on pol activity. V
 
max
 
is a measure of the catalytic rate of the reaction, although it
also could be a measure of product release, whereas K
 
m 
 
most
likely measures the affinity of the pol for the dNTP substrate
(48). In the presence of MSH2–MSH6, the V
 
max 
 
increased
sixfold, and the Km increased 2.5-fold (Table I). As a result,
the catalytic efficiency of nucleotide incorporation (Vmax/
Km) by pol   increased  2.3-fold. It should be noted that
despite the slight increase in Km, the dNTP concentrations
used in the primer extension experiments, as well as the
dNTP levels in cell nuclei (49), are higher than the apparent
Km determined here. Thus, the increased catalytic activity of
pol   is largely due to the effect of the MSH2–MSH6 com-
plex on the Vmax or rate of reaction.
DISCUSSION
Interactions between the MSH2–MSH6 heterodimer and
DNA pol   are of interest because animals deficient for these
proteins have similar phenotypes of fewer mutations of A:T
basepairs in Ig genes, which suggests that they operate to-
gether during hypermutation. In this study, we examined
whether these proteins physically interact and if the interac-
tion affects pol activity. Three different assays were used to
demonstrate binding of the mismatch repair proteins to pol
 . First, intact MSH2–MSH3 and MSH2–MSH6 complexes
bound avidly to pol   in an ELISA assay. Second, to deter-
mine which MSH subunit interacted with pol  , the pro-
teins were individually labeled and incubated with purified
COOH-terminal fragments of pols   and   fused to GST. As
analyzed in a pull-down assay, pol   exhibited strong bind-
ing to MSH2 and weak binding to MSH3 and MSH6, and
pol     had much weaker binding to MSH2 and MSH3.
Third, in HeLa cell extracts, FLAG-tagged pol   coprecipi-
tated with endogenous MSH2, demonstrating that the two
proteins are likely to associate in living cells.
To test for a functional interaction between the protein
complexes, the ability of pol   to elongate a recessed primer
template was measured after the addition of MSH2–MSH6
or MSH2–MSH3 heterodimers. MSH2–MSH6 stimulated
synthesis largely by increasing the Vmax of the reaction, but
did not alter the processivity or fidelity of the enzyme in
these assays. In contrast, although the ELISA and pull-down
experiments suggested that pol   and MSH2–MSH3 physi-
cally interact, MSH2–MSH3 did not affect pol   activity.
Likewise, although the pull-downs showed some interaction
between pol   and MSH2, MSH2–MSH6 did not stimulate
pol   synthesis.
Although we cannot exclude the possibility that interac-
tion with MSH2–MSH6 simply stabilizes pol   in vitro,
leading to a stimulation of its catalytic activity, our data sup-
port the hypothesis that these proteins work together during
somatic hypermutation to produce mutations downstream
of the initial dU lesion at all four bases, including A and T.
One possible scenario is that MSH2–MSH6 first binds to
U:G mismatches that are generated by AID, and then attracts
pol   and other proteins to the site. However, for pol   to
synthesize DNA, a nick must first be generated in the non-
template DNA to allow access of the pol to a 3  primer ter-
Figure 6. Effect of MSH2–MSH6 on processivity and fidelity of pol 
 . The local template sequence is shown to the left of each set of gels. 
(A) Processivity of pol   was measured in the absence and presence of 
MSH2–MSH6 in two-min reactions containing all four nucleotides and 
herring sperm DNA as a trap for pol molecules that dissociate from the 
radiolabeled primer template. (B) Nucleotide incorporation specificity of 
pol   in the absence and presence of MSH2–MSH6 was measured in 10-min 
reactions containing 100  M of each individual nucleotide.
Table I. Kinetic analysis of dTTP incorporation opposite 
template A as catalyzed by pol   in the absence or 
presence of MSH2–MSH6a
Vmax (% 1 min 1)K m ( M) Vmax/Km
Without MSH2–MSH6 3.8   0.6 2.6   0.2 1.4   0.2
With MSH2–MSH6 22.5   5.3 6.7   0.7 3.3   0.6
aData are means (  standard error) from three to five experiments. Vmax/Km values 
are the percentage of primer elongation product per min per  mol of nucleotide.MSH2–MSH6 STIMULATES DNA POLYMERASE   | Wilson et al. 642
minus. There is compelling evidence that the nick is not due
to an endonuclease cleaving at an abasic site that would be
produced after the removal of dU by UNG because ung / 
mice and humans have normal frequencies of substitutions
of A:T (12, 13). Therefore, mutations of A:T pairs can be
produced in the absence of UNG and do not require an aba-
sic site for the mechanism. Nicks might be generated in the
vicinity of the U:G mispair by an endonuclease associated
with MSH2, such as ERCC1-XPF (50, 51) or YB-1 (52).
MSH2 also binds to exonuclease 1 (53), which would pro-
duce a gap at the nick and provide access for pol   to syn-
thesize DNA (54). Alternatively, in a wild-type background,
MSH2–MSH6 might bind to a T:G mispair that has been
erroneously generated during short patch base excision re-
pair of the deaminated cytosine. This may recruit pol   to
the primer terminus, where it extends the repair patch
through strand displacement (43). In either case, as error-
prone synthesis by pol   occurs, mismatches will be gener-
ated opposite neighboring bases. Repeated cycles of MSH2–
MSH6 binding to the mismatches would further stimulate
pol   to make more mutations in the vicinity of the original
cytosine deamination. Further experiments are necessary to
clarify the exact mechanism of how pol   generates muta-
tions of A:T, but it is clear that MSH2–MSH6 plays a cen-
tral role in the process because mice deficient for both UNG
and Msh2 have only mutations of C:G and no mutations of
A:T (55).
MATERIALS AND METHODS
Proteins. Human proteins were used in all of the experiments. MSH2–
MSH6 and MSH2–MSH3 complexes were purified from a baculovirus in-
sect cell system essentially as described previously (56). For the MSH2–
MSH6 complex, the following modifications were performed: peak fractions
eluted from the PBE 94 column were combined and the NaCl concentra-
tion was adjusted to 200 mM with buffer B (50 mM NaCl, 25 mM Hepes-
NaOH, pH 7.9, 1 mM DTT, 0.1 mM EDTA, 10% glycerol, and protease
inhibitors). The sample was then loaded onto a Resource Q column (Amer-
sham Biosciences) preequilibrated with buffer B containing 200 mM NaCl
and eluted with linear gradient of NaCl from 200 mM to 1 M. The MSH2–
MSH6 complex eluted at  450 mM NaCl. The protein fractions were dia-
lyzed and quantified as described previously (57). The MSH2–MSH6 and
MSH2–MSH3 pFastBac Dual expression constructs were provided by R.
Fishel (Thomas Jefferson University, Philadelphia, PA).
For GST pull-down assays, GST-tagged COOH-terminal pols   and  
were made by fusing GST to the COOH-terminal 233 amino acids of pol  
(full-length   713 amino acids) or the COOH-terminal 224 amino acids of
pol   (full-length   715 amino acids). GST-tagged pol   was expressed in
Escherichia coli from plasmid pWC9 and was constructed by PCR amplifica-
tion of the 3  end of pol   cDNA (58) using the following primers: 5 -
GCTAGAAGAATTCTCTAAAGCAACTCCTGC-3   and 5 -AGGCA-
CAGTCGAGGCTGATCAGCGG-3 . The PCR amplicon was digested
with EcoRI and DraI, and the 414-bp product was cloned into the EcoRI–
SmaI-digested GST expression vector, pGEX-4T-1 (Amersham Bio-
sciences). GST-tagged pol   was expressed from plasmid pAR208, whose
construction has been described elsewhere (59). The plasmids were trans-
formed into E. coli BL21 DE3 and induced by the addition of 1 mM isopro-
pyl  -D-thiogalactopyranoside (Sigma-Aldrich). GST-tagged proteins were
bulk purified using glutathione sepharose beads (Amersham Biosciences) ac-
cording to the manufacturer’s instructions. Labeled MSH2, MSH3, and
MSH6 proteins were prepared from pET28a expression vectors that each
contained genes for the three proteins. The vectors were transcribed and
translated in vitro using a TNT Coupled Reticulocyte Lysate System
(Promega) in the presence of [35S]methionine (Amersham Biosciences).
For the ELISA and pol replication assays, recombinant human pol  ,
tagged with (His)6 at its COOH-terminal end, was expressed in Sf9 insect
cells using the baculovirus expression system and prepared as described by
Masutani et al. (47). GST-tagged pol   was purified from baculovirus-
infected insect cells as described previously (60).
ELISA assays. Wells were coated with 500 fmol of either BSA, MSH2–
MSH3, or MSH2–MSH6 proteins diluted in carbonate buffer containing
0.016 M Na2CO3 and 0.034 M NaHCO3, pH 9.8, overnight at 4 C. After
removal of the proteins, the wells were coated with blocking buffer con-
taining 3% BSA and 0.1% TWEEN 20 diluted in PBS and incubated for 1 h
at room temperature. The wells were washed with washing buffer contain-
ing 0.1% TWEEN 20 in PBS. Serial dilutions of pol   in blocking buffer
were then added to each well and incubated at room temperature for 1 h.
After washing the wells with washing buffer, rabbit antibody to COOH-
terminal pol   was diluted at 1:500 in blocking buffer, added to each well,
and incubated for 1 h. The wells were then washed with washing buffer
three times. Goat anti–rabbit IgG antibody conjugated to horseradish per-
oxidase (Vector Laboratories) was diluted at 1:5,000 in blocking buffer,
added to each well for 1 h, and the wells were washed five times with wash-
ing buffer. Bound antibody was detected with o-phenylenediamine dihy-
drochoride followed by termination with 3M H2SO4, and the absorbance
was read at 490 nm. Data were analyzed using the Hill plot according to a
method published previously (61).
Gel mobility shift assays. For generation of DNA substrates contain-
ing a T:G or U:G mismatch, 50-mer oligonucleotides of the following
sequences were obtained from Invitrogen: top strand (5 -CATTATC-
CTAAACATAACTTAACTAGXTTAACTTAATTCTTCAATATACC-
3 ) and bottom strand (5 -GGTATATTGAAGAATTAAGTTAAGCTA-
GTTAAGTTATGTTTAGGATAATG-3 ). For the homoduplex substrate,
X   C; for T:G, X   T; and for U:G, X   U. The bottom strand oligo-
nucleotide was 5  end labeled using  [32P]-ATP and T4 polynucleotide ki-
nase, followed by purification through a ProbeQuant column (Amersham
Biosciences). The labeled strand was then annealed to an equimolar amount
of top strand containing C, T, or U. To generate the abasic and dRP sub-
strates, the duplex U:G mismatched substrate was incubated with UNG and
UNG/Endo IV, respectively, for 20 min at 37 C. The substrates were then
purified by centrifugation through a ProbeQuant column. The DNA bind-
ing assays were performed by incubating increasing concentrations (0,
15, 30, and 60 nM) of the MSH2–MSH6 heterodimer with 1 fmol of the
32P-labeled DNA substrates in a buffer containing 100 mM NaCl, 25 mM
Hepes-NaOH, pH 7.9, 1 mM DTT, 0.5 mM MgCl2, 0.1 mM ADP, 10%
glycerol, 75  g/ml BSA, and 1 pmol of a 200-bp homoduplex competitor in
a final reaction volume of 20  l. The reactions were incubated at 37 C for
20 min followed by electrophoresis on a 5% polyacrylamide (29:1, acryl-
amide/bisacrylamide) gel for 1.5 h at 4 C. The gels were dried, visualized us-
ing a Bio-Rad Laboratories Personal fx PhosphorImager, and the percent
“free” versus “protein-bound” DNA was quantified using ImageQuant soft-
ware. To determine the apparent dissociation constant (Kd) values, nonlinear
regression (curve fit) was performed using GraphPad Prism version 4.00 for
Windows.
GST pull-down assays. GST-tagged COOH-terminal pols   and   or
GST alone was coupled to glutathione sepharose beads and mixed with ei-
ther  35S-labeled MSH2, MSH3, or MSH6 in binding buffer (PBS, 0.2%
Triton-X 100, 5% BSA and protease inhibitor; complete protease inhibitor
cocktail; Boehringer) for 30 min at room temperature. The beads were
washed twice in binding buffer without BSA. The bound proteins were
separated on a 4–15% linear gradient Tris-HCl gel (SDS-PAGE; Bio-Rad
Laboratories) and visualized with a PhosphorImager.
Immunoprecipitation from HeLa cell extracts. HeLa cells were sta-
bly transfected either with a plasmid containing the human pol   geneJEM VOL. 201, February 21, 2005 643
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tagged with a FLAG epitope expressed by a chicken   actin promoter (62),
or with a plasmid containing the FLAG vector alone. Cells were lysed in
TNE buffer (10 mM Tris-HCl, pH 7.8, 1% NP-40, 0.15 M NaCl, and 1
mM EDTA) supplemented with protease inhibitors for 30 min on ice. The
suspensions were centrifuged at 15,000 rpm for 15 min at 4 C. Supernatants
were then collected and protein concentrations were determined. For im-
munoprecipitation, 1 mg of protein was mixed with Dynabeads (Dynal)
coupled to anti–mouse IgG to preclear the lysate. The lysate was then incu-
bated overnight with or without 1  g mouse anti-FLAG antibody. The so-
lution was added to the beads for an overnight incubation and then washed
with TNE buffer five times at 4 C to remove nonspecific proteins. For
Western blotting, the samples were resuspended in loading buffer, boiled
for 5 min, and centrifuged. 40  g of the supernatant protein was loaded
into each lane of a 4–20% SDS polyacrylamide gel and subjected to electro-
phoresis. Proteins were then transferred to a PVDF membrane and stained
with a 1:1,000 dilution of antibodies to FLAG (Sigma-Aldrich) and MSH2
(Santa Cruz Biotechnology, Inc.) and detected by ECL-enhanced chemilu-
minescence (Amersham Biosciences).
Primer extension assays. The sequence of the 40-mer oligonucleotide
templates used in most primer extension experiments is 5 -AGCGTCT-
TAATCTAAGCYXTCGCTATGTTTTCAAGGATTC-3 , where X is
either T, A, G, or C, and Y is either T or A. The sequence of the 18-mer
primer was 5 -TCCTTGAAAACATAGCGA-3 . The sequence of the
40-mer oligonucleotide template used in the mismatch extension experi-
ments is 5 -AGCGTCTTAATCTAAGCTAGCTCGATGTTTTCAAG-
GATTC-3 , and the sequence of the 18-mer primers is 5 -TCCTTG-
AAAACATCGAGX-3 , where X is either C, T, or U.
All primers and templates were synthesized by Loftstrand Laboratories
using standard techniques and were gel purified before use. Primers were 5 
end labeled using T4 polynucleotide kinase and  [32P]-ATP. DNA sub-
strates were prepared by annealing templates with 32P-labeled primers at a
1.5:1 molar ratio. Hybridization was achieved by heating the required mix-
ture of oligonucleotides in an annealing buffer (50 mM Tris-HCl, pH 8, 5
mM MgCl2, 50  g/ml BSA, and 1.42 mM 2-mercaptoethanol) for 10 min
at 100 C followed by slow cooling to room temperature over a period of
 2 h. Annealing efficiencies were  95%, as evidenced by the different mo-
bility of the 32P-labeled primers before and after hybridization to the tem-
plate on nondenaturing polyacrylamide gels. 10 nM primer template (ex-
pressed as primer termini) was incubated with DNA pol   or pol   at 37C 
for 10 min in 10- l reactions containing 100  M of either all four dNTPs
(for primer extension assays) or each dNTP individually (for fidelity assays),
40 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 10 mM dithiothreitol, 250  g/ml
BSA, and 2.5% glycerol in the presence or absence of 150 nM MSH2–
MSH3 or MSH2–MSH6 complex. Reactions catalyzed by pol   also con-
tained 60 mM KCl. Enzyme concentrations are indicated in the figures.
Reactions were terminated by mixing with 10  l formamide loading dye
solution containing 50 mM EDTA, 0.1% xylene cyanol, and 0.1% bro-
mophenol blue in 90% formamide. Before loading onto the gel, the reac-
tions were denatured by heating at 100C  for 10 min and immediately
transferred onto ice for 2 min. Products were resolved by denaturing PAGE
(7 M urea and 15% acrylamide for 3 h at 2,000 V) and then visualized and
quantified using a Molecular Dynamics PhosphorImager and ImageQuant
software. Primer elongation was calculated as percent of total primer ter-
mini and plotted versus enzyme concentration.
To assay the processivity of pol  , primer extension reactions were per-
formed by preincubating the pol alone or in the presence of MSH2–MSH6
with the labeled DNA template for 5 min at room temperature. A mixture of
1  g herring sperm DNA (500 M excess) and 100  M of all four dNTPs was
then added to initiate the reaction. Reactions were terminated after 2 min by
mixing with 10  l of formamide loading dye and analyzed on a polyacryl-
amide gel. The effectiveness of the trap was confirmed by preincubating pol  
with the DNA substrate and excess herring sperm DNA before the addition
of the nucleotides (not depicted). The lack of DNA synthesis in this case ver-
ified that excess herring sperm DNA was sufficient to trap all pol molecules.
Kinetic analysis of replication products. The Km and Vmax for dTTP
incorporation opposite template A were determined by measuring primer
elongation as a function of nucleotide concentration as described previously
(48). Preliminary studies demonstrated that  20% of the primers were ex-
tended to ensure steady-state conditions. 10 nM DNA substrates were repli-
cated for 2 min at 37 C in reaction mixtures containing 5 nM pol  . The
dTTP concentrations ranged from 0.5 to 32  M. Reaction products were
separated in a 20% polyacrylamide gel containing 7 M urea and then visual-
ized and quantified using a PhosphorImager. The velocity of dNTP incorpo-
ration was determined by dividing the percent of product generated by the
respective time of the reaction. The apparent Vmax and Km were determined
from a Hanes-Woolf plot by linear least squares fit using the Sigma Plot soft-
ware. The efficiency of nucleotide insertion by pol was calculated as Vmax/Km.
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